• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » antipsychotics

Articles Tagged with ''antipsychotics''

Expert Q&A

Managing Behavioral and Psychological Disturbances in the Nursing Home

April 1, 2024
Maureen C. Nash, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CGPR_QA2_Maureen-Nash.jpgMaureen C. Nash, MD.

Medical Director, Providence ElderPlace PACE Oregon. Co-editor, Neurocognitive Behavioral Disorders: An Interdisciplinary Approach to Patient-Centered Care (Springer; 2019). All comments are Dr. Nash’s personal views and not those of any organization.

Dr. Nash has no financial relationships with companies related to this material.

Dr. Maureen Nash shares how CMS regulations for using antipsychotics in nursing homes affects quality of care.


Read More
Expert Q&A

Ethical Principles and Capacity Assessment in Dementia Care

April 1, 2024
Paul Appelbaum, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CGPR_QA1_Paul-Appelbaum.jpgPaul S. Appelbaum, MD

Dollard Professor of Psychiatry, Medicine, & Law; Director, Center for Law, Ethics, and Psychiatry, Columbia University, New York, NY. Co-author of Assessing Competence to Consent to Treatment (Oxford University Press; 1998).

Dr. Appelbaum has no financial relationships with companies related to this material.

Dr. Appelbaum provides suggestions on adapting a capacity assessment for people with dementia. 



Read More
Gitlin_image.png
Expert Q&A

Lithium, Antidepressants, and Bipolar Disorder

February 1, 2024
Michael J. Gitlin, M.D.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

TCPR_QA_Gitlin headshot.jpgMichael J. Gitlin, MD.

Professor of Clinical Psychiatry and Director of the Mood Disorders Clinic at the David Geffen School of Medicine at UCLA; coauthor of The Essential Guide to Lithium Treatment (Springer, 2016).

Dr. Gitlin has no financial relationships with companies related to this material.

Practical updates on lithium, antipsychotics, and antidepressants in bipolar disorder.


Read More
Clinical Update

Inpatient Use of Benzodiazepines for Patients With Substance Use Disorders

January 31, 2024
Audrey Abelleira, PharmD, BCPP
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but we must be cautious about prescribing them to patients with substance use disorders (SUDs). Here we review strategies to reduce the risk of benzodiazepine misuse and discuss alternative medication options, including second-generation antipsychotics, antidepressants, gabapentin, and pregabalin.


Read More
shutterstock_2358038753.jpg

A New Form of Lithium

January 8, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

A new formulation of lithium is being developed. Plus updates on lithium in younger, older, and peripartum patients.


Read More
shutterstock_1660489855.jpg

Lithium: 12 Updates from 2023

January 1, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

A year of research on lithium, including updates on its efficacy, renal risks, tremor, and a controlled trial of instant vs. extended release.


Read More
Clinical Update

Negative Symptoms of Schizophrenia

January 1, 2024
Chris Aiken, MD and Paul Riordan, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University, Durham, NC.

The authors have no financial relationships with companies related to this material.

Negative symptoms are the primary cause of disability in schizophrenia, and we identify a few antipsychotics and a few add-on therapies that can help. 


Read More
Research Update

Antipsychotics in Pregnancy and Risk of Neurodevelopmental Disorders

October 3, 2023
Sébastien Hardy, PharmD, BCPS.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sébastien Hardy, PharmD, BCPS. Dr. Hardy has no financial relationships with companies related to this material.

This large study gives us reassuring data about neurodevelopmental outcomes in children exposed to several second-generation antipsychotic medications during pregnancy.


Read More
CHPR Oct-Nov-Dec 2023-HomePage.png
Clinical Update

Postpartum Psychosis: A Primer

October 3, 2023
Victoria Hendrick, MD and Reid Mergler, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Reid Mergler, MD. Assistant Professor of Clinical Psychiatry, Center for Women’s Behavioral Wellness, University of Pennsylvania, Philadelphia, PA. 

Victoria Hendrick, MD. Chief of Inpatient Psychiatry and Clinical Professor, UCLA Medical Center, Los Angeles, CA; Editor-in-Chief, The Carlat Hospital Psychiatry Report.

Dr. Mergler and Dr. Hendrick have no financial relationships with companies related to this material.

Postpartum psychosis can develop very quickly in new mothers who looked well just hours earlier. While rare, it is a true psychiatric emergency. 


Read More
Clinical Update

The Antipsychotic-Stimulant Combo

September 1, 2023
Avneet Soin, MD., Chris Aiken, MD, and Deepti Anbarasan, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Avneet Soin, MD. Psychiatry resident, NYU Grossman School of Medicine. Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.

Deepti Anbarasan, MD. Associate Professor, Psychiatry & Neurology, New York University, New York

Dr. Soin, Dr. Anbarasan, and Dr. Aiken have no financial relationships with companies related to this material.

As antipsychotic indications have spread, more patients are taking them in combination with their opposite: a stimulant. We look at the risks, search for scenarios where it might make sense, and come up with an action plan for this paradoxical pairing.


Read More
Previous 1 2 3 4 5 6 7 8 9 … 17 18 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2639254965.jpg
    General Psychiatry

    Psychopharm Secrets: Starting Meds

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.